Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome

Menopause

Volumn 15, Issue 3, 2008, Pages 524-529

  Joon Cho, Geum ^a   Hyun Lee, Jong ^a   Tae Park, Hyun ^a   Ho Shin, Jung ^a   Cheol Hong, Soon ^a   Kim, Tak ^a   Young Hur, Jun ^a   Wan Lee, Kyu ^a   Kyun Park, Yong ^a   Haeng Kim, Sun ^a,b  

^a Korea University College of Medicine   (South Korea)

^b NONE   (South Korea)

Author keywords

Menopause; Metabolic syndrome

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTMENOPAUSE; RISK FACTOR;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; RISK FACTORS;

EID: 43249124233     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181559860     Document Type: Article

References (35)

1. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
2. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up 14719 initially healthy American women. Circulation 2003;107:391-397.
3. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419.
4. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
5. Morry CC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
7. Oh JY, Hong YS, Sung YA, Barrett-Connor E. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 2004;27:2027-2032.
8. Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006;22:447-454.
9. Lin WY, Yang WS, Lee LT, et al. Insulin resistance, obesity, and metabolic syndrome among non-diabetic pre- and post-menopausal women in North Taiwan. Int J Obes 2006;30:912-917.
10. Choi SH, Ahn CW, Cha BS, et al. The prevalence of the metabolic syndrome in Korean Adults: comparison of WHO and NCEP criteria. Yonsei Med J 2005;46:198-205.
11. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 2004;65:143-149.
12. Choi KM, Lee KW, Kim HY, et al. Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women. Metabolism 2005;54:1510-1514.
13. Simon LA, Friedlander Y, McCallum J, Simons J. Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk. Aust N Z J Med 2000;30:41-47.
14. Zimmet P, Whitehouse S. The effect of age on glucose tolerance: studies in the Polynesian population of Funafuti. Acta Diabetol Lat 1982;19:65-74.
15. World Health Organization Western Pacific Region, International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Australia: Health Communications Australia Pty Limited, 2000.
16. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436.
17. Kim HM, Ryu SY, Park J, Kim J. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001. Diabetes Care 2007;30:701-706.
18. Miller AM, Wilbur J, Chandler PJ, Sorokin O. Cardiovascular disease risk factors and menopausal status in midlife women from the former soviet union. Women Health 2003;38:19-36.
19. Witteman JC, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. BMJ 1989;298:642-644.
20. Amigoni S, Morelli P, Parazzini F, Chatenoud L. Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in Italy. Maturitas 2000;34:25-32.
21. Gruppo di Studio Progetto Menopausa Italia. Risk factors for high blood pressure in women attending menopause clinics in Italy. Maturitas 2006;53:83-88.
22. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995;123:673-675.
23. Zamboni M, Armellini F, Milani MP, et al. Body fat distribution in preand post-menopausal women: metabolic and anthrometric variables and their inter-relationships. Int J Obes Relat Metab Disord 1992;16:495-504.
24. Bjorkelund C, Lissner L, Andersson S, Lapidus L, Bengtsson C. Reproductive history in relation to relative weight and fat distribution. Int J Obes Relat Metab Disord 1996;20:213-219.
25. Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause 2006;13:280-285.
26. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-723.
27. Tanne D, Koren-Morag N, Goldbourt U. Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study. Stroke 2004;35:2351-2355.
28. Otsuki M, Kasayama S, Morita S, et al. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women. Menopause 2007;14:404-407.
29. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990;12:321-331.
30. Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang YF. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001;32:1104-1111.
31. Torng PL, Su TC, Sung FC, et al. Effects on menopause on intraindividual changes in serum lipids, blood pressure, and body weight - the Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis 2002;161:409-415.
32. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447-452.
33. Den Tonkelaar I. Validity and reproducibility of self-reported age at menopause in women participating in the DOM-project. Maturitas 1997;27:117-123.
34. Bean JA, Leeper JD, Wallace RB, Sherman BM, Jagger H. Variations in the reporting of menstrual histories. Am J Epidemiol 1979;109:181-185.
35. Colditz GA, Stampfer MJ, Willett WC, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol 1987;126:319-325.